Business Description

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need.

Company Info

Address:
6555 Carnegie Avenue
4th Floor
Cleveland, OH 44103

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)

SIC:
Pharmaceutical Preparations (2834)